Completed PHASE4 INTERVENTIONAL 9-arm NCT02072525

A Protocol to Collect Human Serum Samples From Healthy Adults for Use as Quality Controls Samples in GlaxoSmithKline (GSK) Biologicals' Assays

A Protocol to Collect Human Serum Samples From Healthy Adults

Sponsor: GlaxoSmithKline

Interventions Boostrix® Menveo® Pneumovax 23® Prevnar 13®

Updated 7 times since 2017 Last updated: Nov 23, 2017 Started: Apr 1, 2014 Primary completion: Jun 2, 2015 Completion: Jun 2, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02072525, this PHASE4 trial focuses on Meningococcal and remains completed. Sponsored by GlaxoSmithKline, it has been updated 7 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Dec 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Feb 2017 — Dec 2017 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Apr 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

GlaxoSmithKline

Data source: GlaxoSmithKline

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sherbrooke, Canada